Latest Krensavage Asset Management, LLC Stock Portfolio
$255Million– No. of Holdings #20
Krensavage Asset Management, LLC Performance:
2026 Q1: 0.01%YTD: 0.01%2025: 55.92%
Performance for 2026 Q1 is 0.01%, and YTD is 0.01%, and 2025 is 55.92%.
About Krensavage Asset Management, LLC and 13F Hedge Fund Stock Holdings
On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Krensavage Asset Management, LLC reported an equity portfolio of $255.7 Millions as of 31 Mar, 2026.
The top stock holdings of Krensavage Asset Management, LLC are UTHR, ENTA, JAZZ. The fund has invested 19.6% of it's portfolio in UNITED THERAPEUTICS CORP and 14.2% of portfolio in ENANTA PHARMACEUTICALS INC.
The fund managers got completely rid off AVADEL PHARMACEUTICALS and CARDINAL HEALTH INC (CAH) stocks. They significantly reduced their stock positions in BIONTECH SE-ADR (BNTX), EXELIXIS INC (EXEL) and SUPERNUS PHARMACEUTICALS INC (SUPN). Krensavage Asset Management, LLC opened new stock positions in INDIVIOR PHARMACEUTICALS INC, EMBECTA CORP (EMBC) and ARDELYX INC (ARDX). The fund showed a lot of confidence in some stocks as they added substantially to ULTRAGENYX PHARMACEUTICAL IN (RARE), BIOGEN INC (BIIB) and EVOLUS INC (EOLS).
The top stock holdings of Krensavage Asset Management, LLC are UTHR, ENTA, JAZZ. The fund has invested 19.6% of it's portfolio in UNITED THERAPEUTICS CORP and 14.2% of portfolio in ENANTA PHARMACEUTICALS INC.
The fund managers got completely rid off AVADEL PHARMACEUTICALS and CARDINAL HEALTH INC (CAH) stocks. They significantly reduced their stock positions in BIONTECH SE-ADR (BNTX), EXELIXIS INC (EXEL) and SUPERNUS PHARMACEUTICALS INC (SUPN). Krensavage Asset Management, LLC opened new stock positions in INDIVIOR PHARMACEUTICALS INC, EMBECTA CORP (EMBC) and ARDELYX INC (ARDX). The fund showed a lot of confidence in some stocks as they added substantially to ULTRAGENYX PHARMACEUTICAL IN (RARE), BIOGEN INC (BIIB) and EVOLUS INC (EOLS).
Krensavage Asset Management, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
Krensavage Asset Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Krensavage Asset Management, LLC made a return of 0.01% in the last quarter. In trailing 12 months, it's portfolio return was 52.43%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| indivior pharmaceuticals inc | 10,349,000 |
| embecta corp | 6,500,000 |
| ardelyx inc | 2,995,000 |
| inmode ltd | 1,654,000 |
| abbott laboratories | 513,000 |
New stocks bought by Krensavage Asset Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| ultragenyx pharmaceutical in | 161 |
| biogen inc | 100 |
| evolus inc | 57.98 |
| enanta pharmaceuticals inc | 3.61 |
Additions to existing portfolio by Krensavage Asset Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| biontech se-adr | -40.19 |
| exelixis inc | -15.77 |
| supernus pharmaceuticals inc | -10.47 |
| united therapeutics corp | -7.67 |
Krensavage Asset Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| avadel pharmaceuticals | -18,444,000 |
| indivior plc | -12,182,000 |
| cardinal health inc | -15,155,000 |
Krensavage Asset Management, LLC got rid off the above stocks
Sector Distribution
Krensavage Asset Management, LLC has about 85% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 85 |
| Others | 15 |
Market Cap. Distribution
Krensavage Asset Management, LLC has about 53.4% of it's portfolio invested in the large-cap and mega-cap stocks.
- LARGE-CAP
- SMALL-CAP
- UNALLOCATED
- MID-CAP
| Category | % |
|---|---|
| LARGE-CAP | 53.4 |
| SMALL-CAP | 24.3 |
| UNALLOCATED | 15 |
| MID-CAP | 7.2 |
Stocks belong to which Index?
About 31.9% of the stocks held by Krensavage Asset Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
- S&P 500
| Index | % |
|---|---|
| Others | 68 |
| RUSSELL 2000 | 29.1 |
| S&P 500 | 2.8 |
Krensavage Asset Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Krensavage Asset Management, LLC
Krensavage Asset Management, LLC has 20 stocks in it's portfolio. About 86.9% of the portfolio is in top 10 stocks. ENTA proved to be the most loss making stock for the portfolio. UTHR was the most profitable stock for Krensavage Asset Management, LLC last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABT | abbott laboratories | 0.20 | 5,000 | 513,000 | new | |||
| ALKS | alkermes plc | 1.49 | 107,822 | 3,813,000 | unchanged | 0.00 | ||
| ARDX | ardelyx inc | 1.17 | 500,000 | 2,995,000 | new | |||
| BIIB | biogen inc | 1.43 | 20,000 | 3,667,000 | added | 100 | ||
| BMRN | biomarin pharmaceutical inc | 11.59 | 524,786 | 29,645,000 | unchanged | 0.00 | ||
| BNTX | biontech se-adr | 2.07 | 59,523 | 5,290,000 | reduced | -40.19 | ||
| CAH | cardinal health inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| EMBC | embecta corp | 2.54 | 735,340 | 6,500,000 | new | |||
| ENTA | enanta pharmaceuticals inc | 14.16 | 2,866,140 | 36,199,000 | added | 3.61 | ||
| EOLS | evolus inc | 0.25 | 157,985 | 649,000 | added | 57.98 | ||
| EXEL | exelixis inc | 6.97 | 415,693 | 17,829,000 | reduced | -15.77 | ||
| GSK | gsk plc-spon adr | 2.09 | 96,729 | 5,338,000 | unchanged | 0.00 | ||
| INMD | inmode ltd | 0.65 | 120,942 | 1,654,000 | new | |||
| JAZZ | jazz pharmaceuticals plc | 12.41 | 167,816 | 31,726,000 | unchanged | 0.00 | ||
| RARE | ultragenyx pharmaceutical in | 3.20 | 390,879 | 8,189,000 | added | 161 | ||
| REGN | regeneron pharmaceuticals | 1.21 | 4,000 | 3,091,000 | unchanged | 0.00 | ||
| SNY | sanofi-adr | 6.10 | 323,946 | 15,608,000 | unchanged | 0.00 | ||
| SUPN | supernus pharmaceuticals inc | 5.67 | 280,681 | 14,508,000 | reduced | -10.47 | ||
| UTHR | united therapeutics corp | 19.55 | 84,282 | 49,978,000 | reduced | -7.67 | ||
| VNDA | vanda pharmaceuticals inc | 3.19 | 1,180,390 | 8,156,000 | unchanged | 0.00 | ||